Pharmacokinetic, biochemical and clinical effects of dimethyltriazenoimidazole-4-carboxamide-bischloroethylnitrosourea combination therapy in patients with advanced breast cancer
Open Access
- 6 December 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 103 (5) , 686-692
- https://doi.org/10.1002/ijc.10849
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Structure, Function, and Inhibition of O6-Alkylguanine-DNA AlkyltransferasePublished by Elsevier ,2008
- O6‐alkylguanine‐DNA alkyltransferase: Role in carcinogenesis and chemotherapyBioEssays, 2002
- Localization of O6-alkylguanine transferase in cancer susceptible cells of human female breastCancer Letters, 1996
- Population and bayesian pharmacokinetics in oncologyClinical Oncology, 1994
- O6-Methylguanine-DNA Methyltransferase in Normal and Malignant Tissue of the BreastCancer Investigation, 1994
- Activity and unexpected lung toxicity of the sequential administration of two alkylating agents—Dacarbazine and fotemustine—in patients with melanomaEuropean Journal Of Cancer, 1993
- Association between growth stimulation by phenobarbital and expression of cytochromes P450 1A1, 1A2, 2B1/2 and 3A1 in hepatic hyperplastic nodules in male F344 ratsCarcinogenesis: Integrative Cancer Research, 1992
- In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogueCancer Chemotherapy and Pharmacology, 1992
- Clinical pharmacokinetics of high-dose DTICCancer Chemotherapy and Pharmacology, 1991
- Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapyCancer Treatment Reviews, 1988